NASDAQ:MORF - Morphic Stock Price, News & Analysis

$19.05
-2.43 (-11.31 %)
(As of 09/17/2019 08:00 AM ET)
Today's Range
$18.33
Now: $19.05
$21.24
50-Day Range
$18.15
MA: $21.90
$28.30
52-Week Range
$15.72
Now: $19.05
$33.50
Volume139,500 shs
Average Volume54,927 shs
Market Capitalization$49.34 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Morphic Holding, Inc., a biopharmaceutical company, focuses on the discovery and development of oral small-molecule integrin therapeutics. The company's lead product candidates in clinical development are MORF-720, a selective oral avb6 specific integrin inhibitor for the treatment of idiopathic pulmonary fibrosis; and a4b7 specific integrin inhibitors for the treatment of inflammatory bowel disease. Its product candidates in discovery stage include an avb1 integrin for the treatment of fibrosis; two TGF-b activations for gastrointestinal cancers and fibrosis; and other aI domain integrins. The company was founded in 2014 and is headquartered in Waltham, Massachusetts.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MORF
CUSIPN/A
CIKN/A
Phone781-996-0955

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees59
Market Cap$49.34 million
Next Earnings Date11/11/2019 (Estimated)
OptionableNot Optionable

Receive MORF News and Ratings via Email

Sign-up to receive the latest news and ratings for MORF and its competitors with MarketBeat's FREE daily newsletter.


Morphic (NASDAQ:MORF) Frequently Asked Questions

What is Morphic's stock symbol?

Morphic trades on the NASDAQ under the ticker symbol "MORF."

How were Morphic's earnings last quarter?

Morphic Holding (NASDAQ:MORF) announced its quarterly earnings data on Monday, August, 12th. The company reported ($4.73) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.40) by $4.33. The firm had revenue of $5.57 million for the quarter, compared to analyst estimates of $8.60 million. View Morphic's Earnings History.

When is Morphic's next earnings date?

Morphic is scheduled to release their next quarterly earnings announcement on Monday, November 11th 2019. View Earnings Estimates for Morphic.

What price target have analysts set for MORF?

4 brokerages have issued 12 month target prices for Morphic's stock. Their forecasts range from $32.00 to $32.00. On average, they expect Morphic's share price to reach $32.00 in the next year. This suggests a possible upside of 68.0% from the stock's current price. View Analyst Price Targets for Morphic.

What is the consensus analysts' recommendation for Morphic?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Morphic in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Morphic.

Has Morphic been receiving favorable news coverage?

News coverage about MORF stock has trended somewhat positive this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Morphic earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Morphic.

Who are some of Morphic's key competitors?

What other stocks do shareholders of Morphic own?

Who are Morphic's key executives?

Morphic's management team includes the folowing people:
  • Dr. Praveen P. Tipirneni M.D., CEO, Pres & Director (Age 50)
  • Dr. Timothy A. Springer Ph.D., Founder, Director & Member of Scientific Advisory Board (Age 71)
  • Mr. Robert E. Farrell Jr., CPA, CPA, VP of Fin. & Operations and Treasurer (Age 54)
  • Dr. Bruce N. Rogers, Chief Scientific Officer (Age 50)
  • Mr. William D. DeVaul Esq., Gen. Counsel & Sec. (Age 48)

When did Morphic IPO?

(MORF) raised $75 million in an initial public offering on Thursday, June 27th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Jefferies, Cowen, BMO Capital Markets and Wells Fargo Securities served as the underwriters for the IPO.

When does the company's lock-up period expire?

Morphic's lock-up period expires on Tuesday, December 24th. Morphic had issued 6,000,000 shares in its initial public offering on June 27th. The total size of the offering was $90,000,000 based on an initial share price of $15.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the expiration of the lock-up period.

Who are Morphic's major shareholders?

Morphic's stock is owned by a number of of retail and institutional investors. Top institutional investors include Omega Fund Management LLC (10.03%), Novo Holdings A S (8.94%), EcoR1 Capital LLC (7.66%), Perceptive Advisors LLC (2.20%), Artal Group S.A. (1.69%) and Pictet Asset Management Ltd. (0.85%). Company insiders that own Morphic stock include Fund V Gp LP Omega, Holdings A/S Novo and Timothy A Springer. View Institutional Ownership Trends for Morphic.

Which institutional investors are buying Morphic stock?

MORF stock was purchased by a variety of institutional investors in the last quarter, including Omega Fund Management LLC, Novo Holdings A S, EcoR1 Capital LLC, Perceptive Advisors LLC, Artal Group S.A., Pictet Asset Management Ltd., Pictet Asset Management Ltd. and Jefferies Group LLC. Company insiders that have bought Morphic stock in the last two years include Fund V Gp LP Omega, Holdings A/S Novo and Timothy A Springer. View Insider Buying and Selling for Morphic.

How do I buy shares of Morphic?

Shares of MORF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Morphic's stock price today?

One share of MORF stock can currently be purchased for approximately $19.05.

How big of a company is Morphic?

Morphic has a market capitalization of $49.34 million. Morphic employs 59 workers across the globe.View Additional Information About Morphic.

What is Morphic's official website?

The official website for Morphic is http://www.morphictx.com/.

How can I contact Morphic?

Morphic's mailing address is 35 GATEHOUSE DRIVE A2, WALTHAM MA, 02451. The company can be reached via phone at 781-996-0955.


MarketBeat Community Rating for Morphic (NASDAQ MORF)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  19 (Vote Outperform)
Underperform Votes:  17 (Vote Underperform)
Total Votes:  36
MarketBeat's community ratings are surveys of what our community members think about Morphic and other stocks. Vote "Outperform" if you believe MORF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MORF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel